["Actinobacillus and Haemophilus parainfluenzae infective endocarditis: two case reports"].
Mai
T
T
Mouly
S
S
Jarrin
I
I
Mahé
I
I
Sellier
P
P
Bergmann
J-F
JF
D000189:Actinobacillus Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004697:Endocarditis, Bacterial / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D005500:Follow-Up Studies; D006192:Haemophilus Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D044135:Haemophilus parainfluenzae / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008875:Middle Aged; D010996:Pleural Effusion / Q000209:etiology; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D002443:Ceftriaxone; D012293:Rifampin